Sinphar Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
409,989.00
207,365.00
58,659.00
34,924.00
52,811.00
87,681
Depreciation, Depletion & Amortization
168,342.00
193,006.00
227,132.00
259,338.00
238,990.00
238,802
Other Funds
222,334.00
4,244.00
1,835.00
26,202.00
1,286.00
46,532
Funds from Operations
320,773.00
305,188.00
122,640.00
102,735.00
174,224.00
104,589
Changes in Working Capital
59,100.00
128,958.00
227,180.00
38,968.00
44,759.00
24,050
Net Operating Cash Flow
261,673.00
176,230.00
349,820.00
141,703.00
218,983.00
80,539
Capital Expenditures
598,159.00
294,291.00
412,041.00
224,849.00
179,409.00
Sale of Fixed Assets & Businesses
1,709.00
3,239.00
342.00
173,626.00
235.00
Purchase/Sale of Investments
143,495.00
53,022.00
50,634.00
225,740.00
49,096.00
Net Investing Cash Flow
617,701.00
369,482.00
480,289.00
30,865.00
266,891.00
Cash Dividends Paid - Total
89,595.00
119,460.00
129,017.00
32,254.00
16,772.00
Issuance/Reduction of Debt, Net
96,886.00
118,378.00
66,322.00
90,560.00
42,958.00
Net Financing Cash Flow
589,691.00
590,724.00
193,504.00
32,104.00
27,472.00
Net Change in Cash
239,358.00
410,442.00
346,093.00
177,914.00
24,732.00
Free Cash Flow
326,645.00
76,054.00
58,276.00
71,209.00
55,594.00
Net Assets from Acquisitions
-
-
-
124,699.00
40,389.00
Other Sources
142,181.00
-
-
4,193.00
1,768.00
Change in Capital Stock
360,066.00
587,562.00
-
-
-
Exchange Rate Effect
5,695.00
12,970.00
22,120.00
26,758.00
4,296.00
Other Uses
19,937.00
25,408.00
17,956.00
23,146.00
-
About Sinphar Pharmaceutical Co.
View Profile
